Utility of positron emission tomography-magnetic resonance imaging in musculoskeletal imaging

被引：0

作者：

Ammar A Chaudhry ^{[1
]}

Maryam Gul ^{[2
]}

Elaine Gould ^{[3
]}

Mathew Teng ^{[3
]}

Kevin Baker ^{[3
]}

Robert Matthews ^{[3
]}

机构：

[1] Department of Radiology, Johns Hopkins Medicine

[2] Department of Rheumatology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health

[3] Department of Radiology, Stony Brook University Hospital

来源：

World Journal of Radiology | 2016年 / 03期

关键词：

Magnetic resonance imaging; Osteosarcoma; Positron emission tomography-magnetic resonance imaging; Osteomyelitis; Positron emission tomographycomputed tomography; Positron emission tomography; Multiple myeloma; Lymphoma;

D O I：

暂无

中图分类号：

R738.1 [骨骼肿瘤]; R445.2 [核磁共振成像]; R730.44 [放射线、同位素诊断];

学科分类号：

100105 ; 100207 ; 100214 ;

摘要：

Differentiation between neoplastic and nonneoplastic conditions magnetic resonance imaging(MRI) has established itself as one of the key clinical tools in evaluation of musculoskeletal pathology. However, MRI still has several key limitations which require supplemental information from additional modalities to complete evaluation of various disorders. This has led to the development hybrid positron emission tomography(PET)-MRI which is rapidly evolving to address key clinical questions by using the morphological strengths of MRI and functional information of PET imaging. In this article, we aim to review physical principles and techniques of PET-MRI and discuss clinical utility of functional information obtained from PET imaging and structural information obtained from MRI imaging for the evaluation of musculoskeletal pathology. More specifically, this review highlights the role of PET-MRI in musculoskeletal oncology including initial diagnosis and staging, treatment planning and posttreatment follow-up. Also we will review utility of PET-MRI in evaluating musculoskeletal infections(especially in the immunocompromised and diabetics) and inflammatory condition. Additionally, common pitfalls of PET-MRI will be addressed.

引用

页码：268 / 274

页数：7

共 9 条

[1]

Paradoxical reduction of cerebral blood flow after acetazolamide loading:a hemodynamic and metabolic study with 15O PET[J]. Tadashi Watabe,Eku Shimosegawa,Hiroki Kato,Kayako Isohashi,Mana Ishibashi,Mitsuaki Tatsumi,Kazuo Kitagawa,Toshiyuki Fujinaka,Toshiki Yoshimine,Jun Hatazawa. Neuroscience Bulletin. 2014(05)

[2]

Principles of PET/MR Imaging[J] . Disselhorst,Jonathan A,Bezrukov,Ilja,Kolb,Armin,Parl,Christoph,Pichler,Bernd J. The Journal of Nuclear Medicine . 2014

[3] Musculoskeletal Applications of PET/MR [J].

Lee, In Sook ;

Jin, Yoo Hye ;

Hong, Sung Hwan ;

Yang, Seoung-Oh .

SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2014, 18 (02) :203-216

[4]

PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner[J] . Franz Wolfgang Hirsch,Bernhard Sattler,Ina Sorge,Lars Kurch,Adrian Viehweger,Lutz Ritter,Peter Werner,Thies Jochimsen,Henryk Barthel,Uta Bierbach,Holger Till,Osama Sabri,Regine Kluge. Pediatric Radiology . 2013 (7)

[5]

Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine*[J] . Fahey,Frederic H,Treves,S Ted,Adelstein,S James. EN . 2012 (1)

[6]

Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma: Pilot Study[J] . Chieh Lin,Emmanuel Itti,Alain Luciani,Benhalima Zegai,Shih-jui Lin,Frédérique Kuhnowski,Frédéric Pigneur,Isabelle Gaillard,Gaetano Paone,Michel Meignan,Corinne Haioun,Alain Rahmouni. Investigative Radiology . 2011 (5)

[7]

Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review[J] . Soni C. Chawla,Noah Federman,Di Zhang,Kristen Nagata,Soujanya Nuthakki,Michael McNitt-Gray,M. Ines Boechat. Pediatric Radiology . 2010 (5)

[8] Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma [J].